Supramolecular collagen composition and application thereof
Through the combination of sulfonated cup aromatic compounds and collagen, the problem of insufficient heat resistance of collagen is solved, significantly improves its thermal stability and maintains biological activity, and is suitable for a variety of skin care products and medical devices.
Patent Information
- Application Number
- CN202411055797.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-02
- Publication Date
- 2024-11-15
AI Technical Summary
Collagen has poor heat resistance, and will undergo thermal degeneration when exposed to high temperatures for a long time and lose its biological activity, resulting in insufficient stability in actual production and transportation.
The combination of sulfonated cup aromatic compounds and collagen is used to incorporate collagen through macrocyclic receptor molecules to protect its secondary structure, thereby improving the thermal stability of collagen.
It significantly improves the thermal stability of collagen, maintains its biological activity, and can be used in a variety of skin care products and medical devices to prevent mutual interference and influence between functional molecules.
Smart Images

Figure CN118948660A_ABST
Abstract
Description
Technical Field
[0001] The present application relates to the field of skin care products, and in particular to a supramolecular collagen composition and its application. Background Art
[0002] Collagen is a type of protein that is widely found in the skin, bones, joints, and hair of mammals, playing a supporting, repairing, and anti-aging role. Due to its good biocompatibility, biodegradability, and biological activity, collagen is increasingly used in health foods, cosmetics, skin care products, medicine, and other fields.
[0003] However, collagen has poor heat resistance and will undergo thermal denaturation (destruction of the secondary structure) when exposed to high temperatures for a long time, thus losing its biological activity. Therefore, it is necessary to develop stabilizers that improve the heat resistance of collagen in actual production and transportation. Summary of the invention
[0004] One object of the present invention is to provide a supramolecular collagen composition, comprising collagen and a sulfonated calixarene compound of formula (I) encapsulating collagen. The composition can maintain the biological activity of collagen at high temperatures, thereby improving the heat resistance of collagen.
[0005]
[0006] in,
[0007] n is an integer selected from 4 to 8,
[0008] M is independently selected from H, alkali metals and alkaline earth metals,
[0009] R is independently selected from C 4-16 Straight chain alkyl.
[0010] In a preferred embodiment, M is at least one metal selected from Na, K, Mg and Ca, more preferably Na.
[0011] In other preferred embodiments, R is selected from C 8-12 The straight chain alkyl group is more preferably dodecyl group.
[0012] In another preferred embodiment, the molar ratio of the sulfonated calixarene compound to collagen is at least 25:1, preferably 30:1, and more preferably 35:1.
[0013] The inventors have found that sulfonated calixarene compounds, as macrocyclic receptor molecules, can protect the secondary structure of collagen by including collagen in the host-guest manner. By applying them to the field of skin care products, new supramolecular collagen formulations can be developed to meet the needs of skin care products for more effective exertion of the biological activity of collagen. Therefore, not only can sulfonated calixarene compounds be used to improve the thermal stability of collagen, but they can also simultaneously include multiple functional molecules including collagen to protect the functions of each molecule from interfering with or affecting each other.
[0014] Another object of the present invention is to provide the use of the sulfonated calixarene compound of formula (I) as a thermal stabilizer for collagen.
[0015] The sulfonated calixarene compound can significantly improve the thermal stability of collagen by being combined and blended with collagen, and can be used as a stabilizer for collagen in skin care products and Class II medical devices. BRIEF DESCRIPTION OF THE DRAWINGS
[0016] Figure 1 a-1h is a graph showing UV spectra of collagen solutions containing sulfonated calixarene compounds at different molar concentrations before and after heating.
[0017] Figure 2 The standard curve shows the concentration and absorbance of collagen in a solution containing 300 μM SC8A-12C.
[0018] Figure 3 a and 3b are CD spectra of collagen solutions with or without the addition of sulfonated calixarene compounds before and after heating.
[0019] Figure 4 a and 4b are UV spectra of the collagen mask liquid with or without the addition of sulfonated calixarene compound before and after heating.
[0020] Figure 5 a and 5b are CD spectra of the collagen mask liquid with or without the addition of sulfonated calixarene compound before and after heating.
[0021] Figure 6 a-6c is a graph showing the UV spectra of collagen solutions to which different sulfonated calixarene compounds were added before and after heating. DETAILED DESCRIPTION
[0022] the term
[0023] Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which the claimed subject matter belongs.
[0024] Unless otherwise indicated, the present invention adopts conventional methods such as mass spectrometry, NMR, HPLC, protein chemistry, biochemistry, recombinant DNA technology and pharmacology within the technical scope of the art. Unless specific definitions are provided, the nomenclature and laboratory operations and techniques related to chemical processes such as analytical chemistry, synthetic organic chemistry, and medical and pharmaceutical chemistry described herein are known to those skilled in the art. In general, the aforementioned techniques and steps can be implemented by conventional methods well known in the art and described in various general and more specific literatures, which are cited and discussed in this specification.
[0025] Supramolecular collagen composition of the present invention and use thereof
[0026] The present invention provides a supramolecular collagen composition, which comprises collagen and a sulfonated calixarene compound of formula (I), wherein the sulfonated calixarene compound of formula (I) can improve the thermal stability of collagen. The sulfonated calixarene compound of formula (I) has the following structure:
[0027]
[0028] in,
[0029] n is an integer selected from 4 to 8, for example 4, 6 or 8,
[0030] M is independently selected from H, alkali metals and alkaline earth metals,
[0031] R is independently selected from C 4-16 Straight chain alkyl.
[0032] In a preferred embodiment, M is at least one metal selected from Na, K, Mg and Ca, more preferably Na.
[0033] In other preferred embodiments, R is selected from C 8-12 The straight chain alkyl group is more preferably dodecyl group.
[0034] Particularly preferably, the sulfonated calixarene compound of the present invention is selected from the following compounds:
[0035]
[0036] In the supramolecular collagen composition of the present invention, the molar ratio of the sulfonated calixarene compound to the collagen is at least 25:1, preferably 30:1, and more preferably 35:1.
[0037] The sulfonated calixarene compound is beneficial to maintaining the secondary structure of collagen and its biological activity by blending it with collagen, and significantly improves the thermal stability of collagen. It can be used as a stabilizer in skin care products and Class II medical devices containing collagen.
[0038] During use, collagen can be used alone or in combination with sulfonated calixarene compounds according to the situation. The supramolecular collagen composition can be used in the following products: skin care creams, lotions, oils, toners, body cleansers, bath products, eye skin care products, facial masks, face washes and other skin care products; foundations, pressed powders, rouges, body makeup, eyebrow drawing, eye shadows, eyelids, eyelashes, eye makeup removers, lip balms, lip gloss oils, general color lipsticks, lip liners and other cosmetics.
[0039] Preparation of Sulfonated Calixarene Compounds
[0040] Compounds of formula (I) may be synthesized using standard synthesis techniques known to those skilled in the art or using methods known in the art in combination with the methods described herein. In addition, the solvents, temperatures and other reaction conditions given herein may be varied according to the art. As further guidance, the following synthesis methods may also be utilized.
[0041] The reactions can be used sequentially to provide compounds described herein; or they can be used to synthesize fragments that are subsequently added by methods described herein and / or known in the art.
[0042] The compounds can be synthesized using methods similar to those described below by using appropriate optional starting materials. The starting materials for synthesizing the compounds described herein can be synthesized or can be obtained from commercial sources. The compounds described herein and other related compounds with different substituents can be synthesized using techniques and raw materials known to those skilled in the art. The general method for preparing the compounds disclosed herein can be from reactions known in the art, and the reactions can be modified by reagents and conditions deemed appropriate by those skilled in the art to introduce various parts into the molecules provided herein.
[0043] If desired, the reaction products can be isolated and purified using conventional techniques, including but not limited to filtration, distillation, crystallization, chromatography, etc. These products can be characterized using conventional methods, including physical constants and spectral data.
[0044] Taking the sulfonated calixarene compound in which R is dodecyl as an example, its synthesis route is as follows.
[0045]
[0046] SC4A-12C: Calix[4]arene (calix[n]arene, n is 4-8, the synthesis process is referred to Org.Synth.1990,68,238; J.Am.Chem.Soc.1982,104,2652; J.Org.Chem.1998,63,489) (2.00 g, 4.71 mmol) was added to a round-bottom flask, 12 mL of concentrated sulfuric acid was slowly added, and the mixture was reacted at 90°C for 4 hours. A small amount of the reaction solution was added to water. If there was no insoluble matter, heating was stopped, the mixture was cooled to room temperature, and the mixture was added dropwise to 400 mL of ether which was stirred rapidly, stirred overnight, and filtered to obtain an off-white solid. The solid was dissolved in a small amount of water, sodium hydroxide (0.77 g, 19.25 mmol) was added, and then a large amount of ethanol was added for recrystallization, and filtered to obtain sulfonated calix[4]arene (SC4A). Dissolve SC4A (3.00 g, 3.60 mmol) and sodium hydroxide (2.35 g, 58.8 mmol) in 15 mL of water, stir for 3 hours, add bromododecane (15.40 g, 61.8 mmol) dissolved in 60 mL of DMSO, and react at 100 degrees Celsius for 5 days. Cool to room temperature, add a large amount of methanol while stirring, and place in a refrigerator to freeze and stand. Filter by suction, dissolve the solid in water, filter out the insoluble matter, add a large amount of ethanol while stirring, and place in a refrigerator to freeze and stand. Filter by suction, and dry to obtain 4.99 g of the product sulfonated calix[4]arene compound (SC4A-12C), with a yield of 92%. 1H NMR(400MHz,DMSO-d6)δ7.08(s,8H,ArH),4.32(d,4H,Ar-CH2-Ar),3.86(t,8H,Ar-O -CH2),3.22(d,4H,Ar-CH2-Ar),1.92(m,8H,-O-CH2-CH2),1.37-1.24(m,72H,alkyl chain),0.85(t,12H,CH3).
[0047] SC6A-12C: Add calix[6]arene (2.00 g, 3.14 mmol) to a round-bottom flask, slowly add 12 mL of concentrated sulfuric acid, and react at 90°C for 4 hours. Take a small amount of the reaction solution in water. If there is no insoluble matter, stop heating, cool to room temperature, and add it dropwise to 400 mL of ether that is stirred rapidly. Stir overnight and filter to obtain an off-white solid. Dissolve the solid in a small amount of water, add sodium hydroxide (0.77 g, 19.25 mmol), then add a large amount of ethanol for recrystallization, and filter to obtain sulfonated calix[6]arene (SC6A). Dissolve SC6A (3.00 g, 2.40 mmol) and sodium hydroxide (2.35 g, 58.8 mmol) in 15 mL of water, stir for 3 hours, add bromododecane (15.40 g, 61.8 mmol) dissolved in 60 mL of DMSO, and react at 100°C for 5 days. Cool to room temperature, add a large amount of methanol while stirring, and place in a refrigerator to freeze and stand. Filter by suction, dissolve the solid in water, filter out the insoluble matter, add a large amount of ethanol while stirring, and place in a refrigerator for freezing. Filter by suction and dry to obtain 5.20 g of the product sulfonated calix[6]arene compound (SC6A-12C), with a yield of 96%. 1HNMR (400MHz, DMSO-d6) δ7.37 (s, 12H, ArH), 4.54 (d, 6H, Ar-CH2-Ar), 3.67 (t, 12H, Ar-O-CH2), 3.43 (d, 6H, Ar-CH2-Ar), 1.82 (m, 12H, -O-CH2-CH2), 1.31-1.22 (m, 108H, alkylchain), 0.85 (t, 18H, CH3).
[0048] SC8A-12C: Add calix[8]arene (2.00 g, 2.36 mmol) to a round-bottom flask, slowly add 12 mL of concentrated sulfuric acid, and react at 90°C for 4 hours. Take a small amount of the reaction solution in water. If there is no insoluble matter, stop heating, cool to room temperature, and drop it into 400 mL of rapidly stirred ether. Stir overnight, filter to obtain an off-white solid, dissolve the solid in a small amount of water, add sodium hydroxide (0.77 g, 19.25 mmol), then add a large amount of ethanol for recrystallization, and filter to obtain sulfonated calix[8]arene (SC8A). Dissolve SC8A (3.00 g, 1.80 mmol) and sodium hydroxide (2.35 g, 58.8 mmol) in 15 mL of water, stir for 3 hours, add bromododecane (15.40 g, 61.8 mmol) dissolved in 60 mL of DMSO, and react at 100°C for 5 days. Cool to room temperature, add a large amount of methanol while stirring, and put it in a refrigerator to freeze and stand. Filter by suction, dissolve the solid in water, filter out the insoluble matter, add a large amount of ethanol while stirring, and place in a refrigerator for freezing and standing. Filter by suction and dry to obtain 4.89 g of the product sulfonated calix[8]arene compound (SC8A-12C), with a yield of 90%. 1HNMR (400MHz, DMSO-d6) δ7.27 (s, 16H, ArH), 4.32 (d, 8H, Ar-CH2-Ar), 3.66-3.56 (m, 24H, Ar-CH2-Ar, Ar-O-CH2), 1.63 (m, 16H, -O-CH2-CH2), 1.37-1.24 (m, 144H, alkyl chain), 0.84 (t, 24H, CH3).
[0049] Test Example
[0050] Example 1: Stabilization test of sulfonated calixarene compounds on collagen solution - UV absorption test
[0051] Test method: UV absorption method.
[0052] Test tools: Japan Shimadzu UV-3600 ultraviolet-visible spectrophotometer, equipped with a temperature control module (model: PTC-348WI). When testing samples, Shimadzu's own quartz cuvette with an optical path of 10 mm was used.
[0053] Reagents: Recombinant humanized type III collagen was purchased from Wuhu Interfil Biopharmaceuticals Industry Research Institute Co., Ltd.
[0054] Aqueous solutions of 10 μM collagen containing different concentrations (0, 20, 50, 100, 200, 250, 300, 350 μM) of SC8A12C were prepared and heated to 60°C for 1 hour. The solution was diluted by appropriate multiples before and after heating to perform UV absorption tests and observe changes in the spectrum. Figure 1a-h frames.
[0055] Figure 1 The results of a-1h show that the recombinant type III humanized collagen has a strong absorption peak near 240nm before heating. The absorption peak near 240nm of the collagen solution without the addition of sulfonated calixarene compound (SC8A12C concentration is 0) is significantly reduced after heating (see Figure 1 a); With the increase of the concentration of sulfonated calixarene compounds, the characteristic absorption peak of the heated collagen solution at around 240nm gradually becomes stronger, and the change in the intensity of the characteristic absorption peak of the collagen at around 240nm before heating gradually decreases, indicating that the stability of the collagen in the heated collagen solution increases with the increase of the concentration of sulfonated calixarene compounds, indicating that sulfonated calixarene compounds have a stabilizing effect on macromolecular recombinant collagen. In particular, when the molar ratio of sulfonated calixarene compounds to collagen reaches 35:1 (see Figure 1 h), as can be seen from the figure, the UV absorption spectra of collagen before and after heating are basically overlapped, indicating that sulfonated calixarene compounds can effectively inhibit the inactivation of collagen caused by heating.
[0056] Furthermore, SC8A12C (300 μM) solutions containing different concentrations (20, 18, 15, 12, 10 μM) of collagen were prepared and diluted appropriately for UV absorption test. The UV absorbance of solutions of different concentrations at 231 nm (the characteristic absorption peak position of collagen) was taken and concentration-absorbance linear fitting was performed to obtain a standard curve of collagen concentration and absorbance: y=0.042x+0.57 (x is the collagen concentration, y is the UV absorbance of the corresponding characteristic absorption peak at 231 nm). The results are shown in Figure 2 .
[0057] Figure 1 The g-band shows that the characteristic absorption peak of collagen is at 231nm, where the absorbance before and after heating is 0.7599 and 0.7504 respectively. Figure 2 The concentration-absorbance standard curve obtained showed that the concentrations of collagen before and after heating were 4.521 μM and 4.295 μM, respectively. The retention rate of collagen in the solution after heating was calculated to be 95% (retention rate = concentration of collagen after heating / concentration of collagen before heating × 100%). This result also proves that sulfonated calixarene compounds can effectively inhibit the inactivation of collagen caused by heating. Example 2: Stabilization test of sulfonated calixarene compounds on collagen solution - collagen secondary structure test
[0058] Test method: Circular dichroism spectroscopy.
[0059] Test tool: BioLogic circular dichroism spectrometer (model: MOS-450)
[0060] A 10 μM aqueous solution of recombinant humanized type III collagen without or with (300 μM) SC8A12C was prepared, heated to 60°C and maintained for 1 hour, and circular dichroism (CD) spectroscopy was performed before and after heating to observe the changes in the spectrum. Figure 3 A and B of the .
[0061] Collagen is composed of a special triple helix structure chain, which is the prerequisite for its biological activity and an important sign of collagen's biological activity.
[0062] Figure 3 The results of a show that before heating, the CD spectrum of collagen has a strong negative absorption characteristic peak at around 197nm and a weak positive absorption characteristic peak at around 220nm; after heating, the absorption characteristic peak at 197nm is significantly reduced and the absorption characteristic peak at 220nm disappears, indicating that the triple helix structure chain of collagen is destroyed. Figure 3 The results in b show that the CD spectra of collagen in the solution containing SC8A12C are basically overlapped before and after heating, indicating that collagen still maintains a good triple helix structure chain and SC8A12C can maintain the secondary structure of collagen.
[0063] Example 3: Stabilization test of sulfonated calixarene compounds on collagen-containing products - UV absorption test
[0064] Test method: UV absorption method.
[0065] Test tools: Japan Shimadzu UV-3600 ultraviolet-visible spectrophotometer, equipped with a temperature control module (model: PTC-348WI). When testing samples, Shimadzu's own quartz cuvette with an optical path of 10 mm was used.
[0066] Reagents: Recombinant humanized type III collagen was purchased from Wuhu Interfil Biopharmaceuticals Industry Research Institute Co., Ltd., and carbomer was purchased from Shanghai Titan Technology Co., Ltd.
[0067] The collagen mask (i.e., collagen-containing product) was prepared according to the formula in Table 1. The fresh mask solutions of the experimental group (the molar ratio of sulfonated calixarene compound SC8A12C to collagen was 30:1) and the control group were heated to 60°C and kept for 1 hour. The solution was diluted by appropriate multiples before and after heating for UV absorption test. The changes in the spectrum were observed. The results are shown in FIG. Figure 4 A and B of the .
[0068] The preparation process of the facial mask liquid of the experimental group is as follows: sprinkle carbomer on the surface of deionized water, soak for 30 minutes, add glycerol and sulfonated calixarene compounds, heat to 80°C until completely dissolved, keep warm for 20 minutes, cool to 45°C, add triethanolamine, continue to cool to 35°C, add recombinant type III humanized collagen and hexanediol, stir evenly, and obtain the facial mask liquid of the collagen mask containing sulfonated calixarene compounds. The preparation process of the control group is the same as that of the experimental group, except that the sulfonated calixarene compounds are not added.
[0069] Table 1 Mask liquid formula of collagen mask
[0070] Figure 4 The results of a and 4b show that after heating the mask solution without adding sulfonated calixarene compounds (SC8A12C concentration is 0), the absorption peak of collagen at 240nm is significantly reduced (see Figure 4 a); while the UV absorption spectra of the mask liquid with sulfonated calixarene compound before and after heating are basically the same (see Figure 4 b), indicating that sulfonated calixarene compounds can effectively improve the thermal stability of collagen and prevent collagen inactivation caused by heating. It is worth noting that the ultraviolet absorption peak at 240nm of the mask liquid without the addition of sulfonated calixarene compounds (SC8A12C concentration is 0) before heating has changed (no longer a sharp peak), which is most likely due to the interaction between collagen and other raw materials in the mask liquid, resulting in the destruction of the collagen structure. After heating, the collagen mask liquid with the addition of sulfonated calixarene compounds can still maintain the same sharp peak at 240nm as before heating, which can further prove that sulfonated calixarene compounds have a protective effect on the structure of collagen.
[0071] Example 4: Irritation test of collagen products containing sulfonated calixarene compounds
[0072] Ten volunteers were recruited and randomly divided into two groups, 5 in each group, as a blank group and an experimental group. Each volunteer cleaned the back of the ear, and used a medical cotton swab to apply about 100 μL of the test substance evenly behind the ear for a sensitivity test behind the ear. After 24 hours of application, observe whether the skin has redness, itching, stinging, rash, desquamation and other phenomena. The test substances of the blank group and the experimental group were purified water and the mask liquid of the collagen mask of the experimental group in Example 3, respectively.
[0073] After 24 hours, no adverse reactions were found in the skin behind the ears of the two groups of volunteers, indicating that the collagen mask liquid of the present invention has low irritation to the skin and meets the safety requirements as a skin care product or a Class II medical device.
[0074] Example 5: Stabilization test of sulfonated calixarene compounds on collagen-containing products - collagen secondary structure test
[0075] Test method: Circular dichroism spectroscopy.
[0076] Test tool: BioLogic circular dichroism spectrometer (model: MOS-450)
[0077] The collagen mask liquid of Example 3 was diluted to an appropriate multiple, heated to 60°C and maintained for 1 hour, and circular dichroism (CD) spectrum test was performed before and after heating to observe the changes in the spectrum. Figure 5 A and B of the .
[0078] Figure 5 a The results show that the CD spectra of the collagen mask without sulfonated calixarene compounds before and after heating change greatly, indicating that the triple helix structure chain of collagen is destroyed; Figure 5 b shows that the CD spectra of the collagen mask with sulfonated calixarene compounds before and after heating are basically the same, indicating that collagen still maintains its original triple helix structure chain and that sulfonated calixarene compounds have a good protective effect on the secondary structure of collagen.
[0079] Example 6: Stabilization test of SC4A12C and SC6A12C on collagen solution - UV absorption test
[0080] Test method:Test method: UV absorption method.
[0081] Test tools: Japan Shimadzu UV-3600 ultraviolet-visible spectrophotometer, equipped with a temperature control module (model: PTC-348WI). When testing samples, Shimadzu's own quartz cuvette with an optical path of 10 mm was used.
[0082] Reagents: Recombinant humanized type III collagen was purchased from Wuhu Interfil Biopharmaceuticals Industry Research Institute Co., Ltd.
[0083] Aqueous solutions containing no sulfonated calixarene compounds and 10 μM recombinant humanized type III collagen containing 300 μM SC4A12C and SC6A12C were prepared respectively, heated to 60°C and maintained for 1 hour, and the solutions were diluted by appropriate multiples before and after heating to perform UV absorption tests and observe changes in the spectrum. Figure 6 a-c.
[0084] Figure 6 a The results show that the UV spectrum of collagen without sulfonated calixarene compounds changed significantly before and after heating, indicating that heating caused the collagen to be inactivated; Figure 6b and 6c show that the UV spectra of the collagen solution with the addition of sulfonated calixarene compounds before and after heating are basically overlapped, indicating that SC4A12C and SC6A12C can effectively inhibit the inactivation of collagen caused by heating.
[0085] Industrial Applicability
[0086] The present invention provides a supramolecular collagen composition and its application, comprising collagen and a sulfonated calixarene compound of formula (I). The sulfonated calixarene compound can significantly improve the thermal stability of collagen by being combined and blended with collagen, and can be used as a stabilizer for collagen in skin care products and Class II medical devices, and is therefore suitable for industrial applications.
Claims
1. A supramolecular collagen composition comprising collagen and a sulfonated calixarene compound of formula (I): in, n is an integer selected from 4 to 8, M is independently selected from H, alkali metals and alkaline earth metals, R is independently selected from C 4-16 Straight chain alkyl.
2. The supramolecular collagen composition according to claim 1, wherein the molar ratio of the sulfonated calixarene compound to the collagen is at least 25:
1.
3. The supramolecular collagen composition according to claim 1, wherein the molar ratio of the sulfonated calixarene compound to the collagen is at least 30:
1. 4 . The supramolecular collagen composition according to claim 1 , wherein the molar ratio of the sulfonated calixarene compound to the collagen is at least 35:
1.
5. The supramolecular collagen composition according to any one of claims 1 to 4, wherein M is at least one metal selected from the group consisting of Na, K, Mg and Ca.
6. The supramolecular collagen composition according to any one of claims 1 to 5, wherein R is selected from C 8-12 Straight chain alkyl.
7. The supramolecular collagen composition as claimed in claim 6, wherein R is selected from dodecyl.
8. Use of the sulfonated calixarene compound of formula (I) as a thermal stabilizer for collagen, in, n is an integer selected from 4 to 8, M is independently selected from H, alkali metals and alkaline earth metals, R is independently selected from C 4-16 Straight chain alkyl.
9. The method according to claim 8, wherein M is at least one metal selected from the group consisting of Na, K, Mg and Ca.
10. The use according to claim 8 or 9, wherein R is selected from C 8-12 Straight chain alkyl.
11. The use according to claim 10, wherein R is selected from dodecyl.
